Floatz logo

ETOPOSIDE

Leukemia

Memorial Sloan Kettering Cancer CenterSmall moleculePhase 3Active
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
71/ 100
Competitive Position
65/ 100

Competitive context

124 Active assets in the Leukemia cohort.

Asset / SponsorPhaseRating
VINCRISTINE SULFATE
Inhye Ahn
Phase 3BB
Idarubicine
Affiliated Hospital of Nantong University
Phase 3BB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BB
THIOGUANINE ANHYDROUS
Incyte Corporation
Phase 3BB
FILGRASTIM
Hospital General de Mexico
Phase 4BB

View all 50 →

Same molecule, other indications

ETOPOSIDE is also rated in:

acute megakaryoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute monocytic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
acute myeloblastic leukemia with maturationDormant
BBB
Indicative ·
79 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →